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EFFECT OF A SIDEROPHORE PRODUCER ON
ANIMAL CELL APOPTOSIS: A POSSIBLE
ROLE AS ANTI-CANCER AGENT
Ismini Nakouti1, Prakitsin Sihanonth2, Tanapat Palaga2 and Glyn Hobbs1*
Research Paper
Iron plays an essential role in the proliferation of aggressive tumors therefore it represents an
ideal target for cancer therapy. Cell free supernatants from a siderophore producing actinobacter
species previously isolated from Thailand were tested against six  human cancer cell lines
including malignant melanoma A 375 (ATCC no.: CRL-1619), colorectal adenocarcinoma SW620
(ATCC no.: CCL-227), gastric carcinoma Katob! (ATCC no.: HTB-103), liver hepatoblastoma
HepG2 (ATCC no.: HB-8065), breast carcinoma BT474 (ATCC no.: HTB-20) and Acute T cell
leukemia Jurkat (ATCC no.: CRL-2063). Following treatment of cells with the  bacterial culture
supernatant the cell viability of A375 cells was dramatically decreased with cell survival of less
than 34 % within 48 h. The rest of the cell lines were largely unaffected. Therefore it is suggested
that the actinobacterium produced a cytotoxic compound  responsible for the cell death by
inducing apoptotic activity. We further speculate that this compound was desferioxamine E as
the bacterium is known to produce this compound under the culture conditions used.
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INTRODUCTION
Cancer cells have an increased requirement for
iron compared with ‘healthy’ cells due to their rapid
division. They also posess a higher rate of iron
uptake and storage (Elford et al., 1970; Vaughn,
1987). Moreover the ribonucleotide reductase
(RR) enzyme involved in DNA synthesis is
upregulated in cancerous cells leading to
increased DNA replication and cell proliferation
(Buss et al., 2003; Dayani et al., 2004,
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Richardson, 1997). Iron is fundamental for the
activity of RR making iron an obvious anti-cancer
candidate (Thelander and Gräslund, 1983;
Whitnall et al., 2006).
Siderophores are low molecular weight
compounds (600-1500 Daltons) that chelate ferric
complexes and other ions with a high affinity. Due
to the role of iron in cellular proliferation, iron
chelators, such as siderophores, are agents that
may be beneficial for the treatment of cancer
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(Wandersman and Delepelaire, 2004). Indeed
some data demonstrated that desferrioxamines
(iron-free siderophores) can significantly reduce
the growth of aggresive tumours in patients
suffering from neuroblastom (NB) or leukemia
(Buss et al., 2003; Lovejoy and Richardson,
2003). Clinical studies have demonstrated that
following a 4 h incubation desferrioxamine can
inhibit DNA replication of NB cells (Blatt et al.,
1988). In addition a 72 h exposure of NB cells to
60 Figure 1(a)M of desferrioxamine reduces the
cells’ viability by 80 % (Blatt and Stitely, 1987).
An actinobacterium (GenBank accession
number EF585403), previously isolated from Tak
province in Thailand, was tested positive for
siderophore production and its main chelating
agent released was identified as desferrioxamine
E by HPLC analysis (Nakoutiet al., 2012). The
aim of this work was to screen the culture
supernatant for anti-cancer activity using a range
of cancerous cell lines and to investigate if a
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 (0.1 g) and bacteriological agar (20 g)
were dissolved in 1 litre of distilled H
2
O and
sterilised by autoclaving at 1210C for 15 min (solid
media). Liquid media were prepared by omitting
the bacteriological agar.
Culture Conditions
Spores of the strain were stored in a bacterial
preservation system (Technical Service Consul-
tants Ltd, Lancashire) at -800C and 10 l were
spread onto starch casein agar plates and
incubated at 300 C for a week until sporulation
occurred. Fresh spores were collected
aseptically (in 20 ml of sterile distilled H
2
O) and
an aliquot (100 l) was introduced into a 250 ml
conical flask containing 50 ml of sterile starch
casein media (liquid). The cultures were
supplemented with 5 g/L lysine prior to incubation
on a rotary shaker (200 rpm) at 300 C for 4 days.
The conditions were previously optimised for
maximum desferrioxamine E production (Nakouti
and Hobbs, 2012). Following incubation the
medium was centrifuged for 20 min at 8000 g to
separate the mycelia. The supernatant was filter-
sterilised by using a 0.20 Figure 1(a)m syringe
filter (Corning) and stored at 40C.
Biological Assay of Anticancer Activity
The effect of the culture supernatant on the cell
viability was assessed using the MTT assay
(Palaga et al., 1996) against 6 human cancer cell
lines including malignant melanoma A375 (ATCC
no. CRL-1619), colorectal adenocarcinoma
SW620 (ATCC no. CCL-227), gastric carcinoma
Katob! (ATCC no. HTB-103), liver hepato-
blastoma HepG2 (ATCC no. HB-8065), breast
carcinoma BT474 (ATCC no. HTB-20) and Acute
T cell leukemia Jurkat (ATCC no. CRL-2063). Cell
suspensions in PRMI-1640 medium supplemented
with 10% (v/v) fetal bovine serum and 100 mg/ml
gentamicin were seeded into flat-bottomed 96-
well plates at a density of 2-3 x 104 cells/well and
incubated at 37°C in a 5 % CO
2 
atmosphere for
24 h. An aliquot (50 l) of the culture supernatant
was added to the well and incubated (48 h contact
time) under the same conditions.









) x 100 % while absorbance (540 nm)
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obtained from cells incubated with sterile PRMI-
1640 medium was used as the control (positive)
and cell free medium as the blank (negative).
Ferrichrome (iron-free) from Ustilago
sphaerogena (5l of 1 mg/ml concentration) was
also tested against the cell lines for anti-cancer
activity. The reason behind this was that
desferrioxamine E was not available in the
market; therefore ferrichrome, also a
hydroxamate, was purchased from Sigma-
Aldrich.
Apoptosis Tests
A cell culture dish (35 x 10 mm) containing a
sterile glass coverslip in RPMI-1640 medium was
seeded with a cell suspention of A375 cells (final
concentration of 1 x 106 cells/ml). The cells were
allowed to attach for 24 h, followed by treatment
for 48 h. They were then washed with phosphate
buffer saline (PBS), f ixed with 1% (v/v)
glutaraldehyde in the dark for 2 h and washed
with PBS. Cells which had attached to the glass
coverslips, were stained with DNA dye Hoechst
33342. After being left for 5 min in the dark,
apoptotic cell death was determined by observing
fragmented nuclei cells under the fluorescent
microscope (modified from [14]).
RESULTS AND DISCUSSION
Anticancer Activity
The effect of the strain’s supernatant on cellular
viability was assessed using the MTT assay. The
isolate was found to produce strong cytotoxic
substances specific to malignant melanoma cells
(A375). Following treatment of cells with the
culture supernatant (50 l) the percentage cell
viability of A375 cells was dramatically decreased
with cell survival of less than 34 % (33.193 %)
within 48 h (Table 1); whereas the remaining
cancer cell lines exhibited similar cell viability. The
experiment was an average of 12 replicates.
Therefore it was suggested that the organism
exhibited selective activity against the skin cancer
cell line. Ferrichrome produced by Ustilago
sphaerogena had little effect on any of the cancer
cell lines (cell viability after treatement was
measured to be 94 %).
Induction of Apoptosis by Streptomyces
sp. Strain 23F
The supernatant (50 l) of strain 23F (GenBank
accession number EF585403) was tested for
induction of apoptosis with malignant melanoma
cells (A375). Addition of the supernatant to A375
cell culture resulted in the induction of apoptotic
Samples 1 2 3 4 5 6 7 8 9 10 11 12
Mean Viabi- STD
lity (%) (%)
Blank 0.038 0.035 0.035 0.035 0.035 0.038 0.038 0.035 0.035 0.035 0.038 0.038 0.036 0 N/A
Control 1.178 1.226 1.293 1.190 1.198 1.227 1.210 1.293 1.193 1.224 1.194 1.290 1.226 100 N/A




Treated 1.166 1.101 1.109 1.190 1.192 1.105 1.170 1.163 1.199 1.169 1.196 1.166 1.160 94 +/–2.877
with
ferrichrome
Table 1: MTT Assay Data Demonstrating the Anticancer Activity
of the Siderophore Producer Supernatant
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Figure 1: A375 Cancer Cells Stained with Hoechst, the Apoptotic Nuclei
were Visualised Under the Fluorescent Microscope (X 40 Magnification)
Figure 2: A375 Cells Treated with Starch Casein Media (Negative Control),
Cell Division is Evident (x 40 Magnification)
activity. Cells from the culture were stained with
Hoechst dye and apoptotic nuclei were visualised
under the fluorescent microscope (Figure 1). The
cancer cells (A375) became smaller through
shrinking and the chromatin became agglutinated
resulting in nuclear condensation followed by
breakdown of the nuclear membrane. The
remaining ‘attached’ cells appeared very similar
to the untreated ones. Cells treated with sterile
starch casein media (negative control) did not
display any DNA fragmentation and appeared
similar to untreated cells (Figure 2). The results
suggested that the cytotoxic compound has
induced apoptosis in the A375 cell line.
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CONCLUSION
The actinobacterium (GenBank accession
number EF585403) released a cytotoxic
substance that induced apoptosis to malignant
melanoma A375 (ATCC no. CRL-1619).
AKNOWLEDGMENT
I would like to that the Society For General
Microbiology for awarding me the President’s
Fund. I would also like to thank Prof Prakitsin
Sihanoth and Dr. Tanapat Palaga for allowing me
to conduct my research in their laboratories.
REFERENCES
1. Blatt J, Taylor SR and Stitely S (1988),
“Mechanism of antineuroblastoma activity
of deferoxamine in vitro”, J. Lab. Clin. Med.,
vol. 112, pp. 433-436.
2. Blatt J and Stitely S (19870, “Antineuro-
blastoma activity of desferoxamine in
human cell lines”, Cancer Res., Vol. 47, pp.
1749-1750.
3. Buss J L, Torti F M and Torti SV (2003), “The
role of iron chelation in cancer therapy”,
Curr. Med. Chem., Vol. 10, pp. 1021-1034.
4. Dayani PN, Bishop MC, Black K and Zeltzer
PM (2004), “Desferoxamine (DFO)-media-
ted iron chelation: rationale for a novel
approach to therapy for brain cancer”, J.
Neurooncol., Vol. 67, pp. 367-377.
5. Elford HL, Freese M, Passamani E and
Morris H P (1970), “Ribonucleotide
reductase and cell proliferation”, J. Biol.
Chem., Vol. 245, pp. 5228-5233.
6. Lovejoy D B and Richardson D R (2003),
“Iron chelators as anti-neoplastic agents:
current developments and promise of the
PIH class of chelators”, Cur. Med. Chem.,
Vol. 10, pp. 1035-1049.
7. Nakouti I, Sihanonth P and Hobbs G (2012),
“A new approach to isolating siderophore
producing actinobacteria”, Lett. Appl.
Microbiol., Vol. 55, pp. 68-72.
8. Nakouti I and Hobbs G (2012), “A new
approach to studying ion uptake by
actinomycetes”, J. Basic. Microbiol., in
press.
9. Palaga T, Kataoka T, Woo J T and Nagai K
(1996), “Suppression of apoptotic cell death
of IL-3-dependent cell line by ER/ SR Ca2+-
ATPase inhibitors upon IL-3 deprivation”,
Exp. Cell. Res., Vol. 228, pp. 92-97.
10. Richardson D R (1997), “Iron chelators as
effective anti-proliferative agents”, Can. J.
Physiol. Pharmacol., Vol. 75, pp.164-1180.
11. Thelander L and Gräslund A (1983),
“Mechanism of inhibition of mammalian
ribonucleotide reductase by the iron chelate
of 1-formylisoquinoline thiosemicarbazone”,
J. Biol. Chem., Vol. 258, pp. 4063-4066.
12. Vaughn C B, Weinstein R, Bond B, Rice R,
Vaughn R W, McKendrick A, Ayad G,
Rockwell M A and Rocchio R (1987), “Ferritin
content in human cancerous and
noncancerous colonic tissue”, Cancer
Invest., Vol. 5, pp. 7-10.
13. Wandersman C and Delepelaire P (2004),
“Bacterial iron sources: from siderophores
to hemophores”, Annu. Rev. Microbiol., Vol.
58, pp. 611-647.
14. Whitnall M, Howard J, Ponka P and
Richardson D R (2006), “A class of iron
chelators with a wide spectrum of potent
antitumor activity that overcomes resistance
to chemotherapeutics”, Proc. Natl. Acad.
Sci., vo. 103, pp. 14901-14906.
